IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosisRossana G. Iannitti, Luigina Romani, Cristina Massi-Benedetti et al.|Nature Communications|2016Cited by 232
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosisSilvia Moretti, Luigina Romani, Giorgia Renga et al.|Nature Communications|2017Cited by 129
Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?Gemma Conte, Francesca Ungaro, Gabriella Costabile et al.|ACS Applied Materials & Interfaces|2022Cited by 96